- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Emcure Pharmaceuticals Limited — Board Meeting, 06-08-2026: Outcome of Board Meeting
06-08-2026 | 01:42 pm
06-08-2026 | 01:42 pm
Emcure Pharma's Q1 FY27 consolidated revenue surged 22.8% to ₹2,580.4 Cr, PAT jumped 36.2% to ₹292.5 Cr. The board approved results, named Satish Mehta as new Chairman & Samit Mehta as COO. Also, Gennova Biopharma is now a wholly-owned subsidiary.
No comments yet. Be the first to comment!